Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Gaebel

Showing results (161-170 of 192) with videos related to

Pageof 20
Sort By:
European Psychiatry : the Journal of the Association of European Psychiatrists|March 17, 2021
EPA guidance on treatment of negative symptoms in schizophreniaS Galderisi, S Kaiser, I Bitter, et al.
Der Nervenarzt|January 21, 2014
[Mental disorders in the general population : Study on the health of adults in Germany and the additional module mental health (DEGS1-MH)]F Jacobi, M Höfler, J Strehle, et al.
Der Nervenarzt|November 26, 2015
[Erratum to: Mental disorders in the general population. Study on the health of adults in Germany and the additional module mental health (DEGS1-MH)]F Jacobi, M Höfler, J Strehle, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|February 18, 2021
EPA guidance on assessment of negative symptoms in schizophreniaS Galderisi, A Mucci, S Dollfus, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|March 5, 2015
EPA guidance on the role and responsibilities of psychiatristsD Bhugra, A Ventriglio, M R Kuzman, et al.
European Journal of Neurology|May 7, 2010
A novel MRI-biomarker candidate for Alzheimer's disease composed of regional brain volume and perfusion variablesC Luckhaus, M Jänner, M Cohnen, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|March 5, 2015
EPA guidance on how to improve the image of psychiatry and of the psychiatristD Bhugra, N Sartorius, A Fiorillo, et al.
Der Nervenarzt|December 16, 2004
[Data supporting quality circle management of inpatient depression treatment]S Brand, M Härter, P Sitta, et al.
Pharmacopsychiatry|October 29, 2010
Relationship between baseline severity of depression and antidepressant treatment outcomeV Henkel, F Seemüller, M Obermeier, et al.
Pharmacopsychiatry|November 17, 2004
Etiopathogenetic mechanisms in long-term course of schizophreniaP Falkai, R Tepest, T G Schulze, et al.
Pageof 20

Showing results (161-170 of 192) with videos related to

Sort By:
Pageof 20
European Psychiatry : the Journal of the Association of European Psychiatrists|March 17, 2021
EPA guidance on treatment of negative symptoms in schizophreniaS Galderisi, S Kaiser, I Bitter, et al.
Der Nervenarzt|January 21, 2014
[Mental disorders in the general population : Study on the health of adults in Germany and the additional module mental health (DEGS1-MH)]F Jacobi, M Höfler, J Strehle, et al.
Der Nervenarzt|November 26, 2015
[Erratum to: Mental disorders in the general population. Study on the health of adults in Germany and the additional module mental health (DEGS1-MH)]F Jacobi, M Höfler, J Strehle, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|February 18, 2021
EPA guidance on assessment of negative symptoms in schizophreniaS Galderisi, A Mucci, S Dollfus, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|March 5, 2015
EPA guidance on the role and responsibilities of psychiatristsD Bhugra, A Ventriglio, M R Kuzman, et al.
European Journal of Neurology|May 7, 2010
A novel MRI-biomarker candidate for Alzheimer's disease composed of regional brain volume and perfusion variablesC Luckhaus, M Jänner, M Cohnen, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|March 5, 2015
EPA guidance on how to improve the image of psychiatry and of the psychiatristD Bhugra, N Sartorius, A Fiorillo, et al.
Der Nervenarzt|December 16, 2004
[Data supporting quality circle management of inpatient depression treatment]S Brand, M Härter, P Sitta, et al.
Pharmacopsychiatry|October 29, 2010
Relationship between baseline severity of depression and antidepressant treatment outcomeV Henkel, F Seemüller, M Obermeier, et al.
Pharmacopsychiatry|November 17, 2004
Etiopathogenetic mechanisms in long-term course of schizophreniaP Falkai, R Tepest, T G Schulze, et al.
Pageof 20